The 2022 Annual Conference of ISHR-NAS: Advances in Cardiovascular Medicine Through Diversity, Equity, and Inclusion; Focusing on Education and Technological Innovation

ISHR-NAS 2022 年年会：通过多样性、公平和包容性推动心血管医学进展；

• 批准号: 10540615
• 负责人: Peipei Ping
• 金额: $ 1万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-08-01 至 2023-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10540615
• 关键词: Academia; Administrator; Advocate; Aging; American; Award; Basic Science; Big Data; Biology; Canada; Cardiac health; Cardiovascular Diseases; Cardiovascular system; Career Mobility; Cities; Clinical Sciences; Colorado; Communities; Development; Diagnosis; Discipline; Disease; Education; Educational workshop; Environment; Epigenetic Process; Evaluation; Event; Female; Fostering; Friends; Functional disorder; Funding Agency; Generations; Goals; Government; Growth; Health; Heart Diseases; Heart Research; Heart failure; Individual; Industrialization; Industry; Institution; International; Investments; Knowledge; Leadership; Location; Logistics; Marriage; Medicine; Metabolism; Minority Groups; Mission; Molecular; National Heart, Lung, and Blood Institute; Nutritional status; Participant; Phase; Phenotype; Physicians; Plant Roots; Prevention; Prevention strategy; Private Sector; Proteomics; Published Comment; Request for Proposals; Research; Research Personnel; Role; Schedule; Science; Scientist; Series; Societies; System; Technology; Training; Translating; Translations; Travel; Underrepresented Minority; Woman; academic program; base; cardiovascular health; career; clinical practice; community building; disorder prevention; diversity and equity; education research; experience; gender difference; hormone therapy; innovation; insight; lectures; meetings; member; novel; novel strategies; operation; programs; rapid growth; success; symposium; technological innovation; translational medicine

This proposal requests NHLBI’s support for the 41st Annual Conference of the International Society for Heart Research (ISHR)—North American Section (NAS) in 2022. As the current President of ISHR-NAS (2018-2021), it is my great honor to serve as the PI of this R13 application and together with my colleagues on the NAS leadership team, Dr. Lorri Kirshenbaum (conference chair), Dr. Maria Kontaridis and Dr. Jennifer Van Eyk (conference co-chairs), Dr. David Lefer, the next NAS President (2022-2024), and Ms. Kelley Brodsky (Executive Administrator), we will continue the success in ISHR-NAS meetings. Our ISHR-NAS 2021 meeting in Denver was an excellent success; we are confident based on the steady growth of NAS membership over the past four years that this 2022 meeting will attract approximately 250-300 attendees. Since spring of 2021, we have been working together to plan a first-class conference with broad impact in cardiovascular biology and medicine. Together, the meeting organizers have extensive experience in implementing national and international conferences, and our scientific expertise covers a broad range of disciplines. We fully anticipate that this outstanding team will make the 2022 ISHR-NAS conference another riveting success. Our goals will be supported by these aims: Aim 1 is to elevate and enrich the careers of young investigators in order to facilitate their launch. Aim 2 is to illuminate recent scientific developments in unique cardiovascular domains via the marriage of basic and clinical science with industrial participation. Aim 3 is to present state-of- the-art cardiovascular science through interactive domains, including panel discussions where candid, direct debates on challenges and important issues faced by the cardiovascular community are emphasized. Many components of the meeting are deeply rooted in promoting Diversity, Equity, and Inclusion in cardiovascular medicine. This meeting contains a vibrant scientific program that features special 1-day sessions for ECIs and MCIs, 21 scientific symposia, 2 young investigator competitions, 5 workshops, 3 featured lectures, and several community- building networking events. The preliminary program contains a total of 104 invited speakers and panelists (~80% confirmed, 51% are female), representing premier academic programs and industrial research entities located from 35 cities across 24 States in the US and 6 cities in Canada. By implementing mechanisms to maximize the participation of female and URM speakers, this meeting offers valuable opportunities to support the ISHR-NAS mission on Diversity, Equity, and Inclusion. The preliminary program consists of greater than 50% female. Moreover, we have allocated 30 travel awards specifically for underrepresented minority groups (URMs) in order to further promote equality and equal opportunities. Every aspect of the meeting will go to support the NHLBI mission of promoting the prevention and treatment of heart diseases and enhancing the health of individuals.

该提案请求 NHLBI 支持国际心脏学会第 41 届年会 研究（ISHR）—2022 年北美分部（NAS）。作为 ISHR-NAS 现任主席（2018-2021）， 我很荣幸能够担任这个 R13 应用程序的 PI 并与 NAS 的同事一起工作 领导团队：Lorri Kirshenbaum 博士（会议主席）、Maria Kontaridis 博士和 Jennifer Van Eyk 博士 （会议联合主席）、下一任 NAS 主席（2022-2024 年）David Lefer 博士和 Kelley Brodsky 女士（执行主席） 管理员），我们将继续在丹佛举行的 ISHR-NAS 2021 会议取得成功。 取得了巨大的成功；基于过去四年 NAS 会员的稳定增长，我们充满信心 自 2021 年春季以来，我们预计 2022 年的会议将吸引大约 250-300 名与会者。 共同策划一次在心血管生物学和医学领域具有广泛影响的一流会议。 会议组织者在实施国内和国际会议方面拥有丰富的经验。 会议，我们的科学专业知识涵盖广泛的学科，我们完全预料到这一点。 优秀的团队将使2022年ISHR-NAS会议再次取得圆满成功。 我们的目标将得到以下目标的支持： 目标 1 是提升和丰富年轻研究人员的职业生涯 为了促进其推出，目标 2 是阐明独特心血管领域的最新科学进展。 通过将基础科学和临床科学与工业参与结合起来的领域目标 3 是展示现状。 通过互动领域展示最先进的心血管科学，包括坦诚、直接的小组讨论 强调了心血管界面临的挑战和重要问题的辩论。 会议的组成部分深深植根于促进心血管领域的多样性、公平性和包容性 药品。 这次会议包含一个充满活力的科学计划，其中包括针对 ECI 和 MCI 的为期 1 天的特别会议，21 科学研讨会、2 场青年研究者竞赛、5 场研讨会、3 场特色讲座以及数场社区活动 初步计划共有 104 名受邀演讲者和小组成员。 （约 80% 已确认，51% 为女性），代表顶级学术项目和工业研究实体 分布在美国 24 个州的 35 个城市和加拿大的 6 个城市。 最大限度地提高女性和 URM 发言人的参与，本次会议提供了宝贵的机会来支持 ISHR-NAS 的多元化、公平性和包容性使命初步计划包括以下内容。 此外，50% 为女性，我们专门为代表性不足的少数群体分配了 30 个旅行奖励。 （URM）为了进一步促进平等和机会均等，会议的各个方面都将进行。 支持 NHLBI 促进心脏病的预防和治疗并提高健康水平的使命 个人的健康。